Yüklüyor......
Prognostic Role of Methylation Status of the MGMT Promoter Determined Quantitatively by Pyrosequencing in Glioblastoma Patients
OBJECTIVE: This study investigated whether pyrosequencing can be used to determine the methylation status of the MGMT promoter as a clinical biomarker using relatively old archival tissue samples of glioblastoma. We also examined other prognostic factors for survival of glioblastoma patients. METHOD...
Kaydedildi:
| Yayımlandı: | J Korean Neurosurg Soc |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
The Korean Neurosurgical Society
2016
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4754584/ https://ncbi.nlm.nih.gov/pubmed/26885283 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3340/jkns.2016.59.1.26 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|